Action supports Boehringer Ingelheim at two regional respiratory events
The past month was action-packed for our International Client Hub who went all out with final preparations for two big client events, culminating at the start of April! The team supported their longstanding client, Boehringer Ingelheim, one of the pharmaceutical industry’s top 20 companies, in two regional events focusing on respiratory topics.
The first event, the First Central and Eastern European CTD-ILD Summit (CECILD), brought over 100 leading experts from the region together in Budapest to discuss the latest updates in relation to the diagnosis and treatment of systemic sclerosis-associated interstitial lung disease and other connective tissue interstitial lung diseases. The second event, the 5th Central & Eastern European IPF Platform (CIPF), took place in Geneva, and saw over 150 experts come together to discuss the latest developments in idiopathic pulmonary fibrosis.
At both events, Action was responsible for coordinating the media attendance from across the CEE and wider region and running a media workshop, with expert speakers sharing their insights and giving one-on-one interviews.